Identification of a six-gene signature to predict survival and immunotherapy effectiveness of gastric cancer

BACKGROUND: Gastric cancer (GC) ranks as the fifth most prevalent malignancy and the second leading cause of oncologic mortality globally. Despite staging guidelines and standard treatment protocols, significant heterogeneity exists in patient survival and response to therapy for GC. Thus, an increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Zhang, Biyuan, Wang, Haiji, Hu, Mingming, Feng, Hui, Gao, Wen, Lu, Haijun, Tan, Ye, Dong, Yinying, Xu, Mingjin, Guo, Tianhui, Ji, Xiaomeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316024/
https://www.ncbi.nlm.nih.gov/pubmed/37404760
http://dx.doi.org/10.3389/fonc.2023.1210994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316024/
https://www.ncbi.nlm.nih.gov/pubmed/37404760
http://dx.doi.org/10.3389/fonc.2023.1210994

Ejemplares similares